Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab

M Walraven, Marjolein Homs, Astrid van der Veldt, H Dekker, J Koldenhof, R Honeywell, A Barendrecht, SAE Sebastian, N Parr, AC Koekman, EE Voest, M Roest, SJA Korporaal, HMW Verheul

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Scopus)
2 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)325-334
Number of pages10
Issue number2
Publication statusPublished - 2018

Cite this